IPO
All investments in healthcare businesses progressing as planned to further accelerate growth
Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT
The report summarises the business and highlights for 2018 and gives insights into the company’s strategy.
Promore Pharma AB calls for Annual General Meeting Tuesday 21 May 2019 at 2 pm at Wenner-Gren Center, Biblioteket, plan 24, Sveavägen 166, in Stockholm.
CEVEC Pharmaceuticals GmbH announced the successful closing of a Series D financing round with new and existing investors.
BioArctic AB announced that the Annual Report for the 2018 fiscal year has been published.
Auris Medical Holding Ltd. announced that the Nasdaq Hearings Panel has granted the Company’s request for the continued listing of the Company’s securities on The Nasdaq Capital Market.
ADOCIA announces its financial results, including revenue and cash position, for the quarter ended March 31st, 2019.
Although 2018 marked a record year for biopharma initial public offerings (IPO), 2019 has had a number of IPOs so far as well. Here’s a look at four recent IPO filings—and $86 million appears to be the magic number.
NOXXON Pharma N.V. announced its financial results for the fiscal year ending December 31, 2018.
PRESS RELEASES